HTG Therapeutics White Paper HTP Proof of Concept
A Proof-of-concept Exploration of Transcriptome-informed
Drug Discovery Using the HTG Transcriptome Panel
- Categories
- White Papers
- Therapeutics
A Proof-of-concept Exploration of Transcriptome-informed
Drug Discovery Using the HTG Transcriptome Panel
Paurnima, P., et al., T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level
Powles, T., et al., Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial
Bhattacharya, A., et al., Placental genomics mediates genetic associations with complex health traits and disease
Akula, S., et al., Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene
Cheang, M. et al., Abstract PD2-07: Impact of using cross-platform gene expression profiling technologies and computational methods for intrinsic breast cancer subtyping in PALOMA-2 and PALLET
Denkert, C., et al., Abstract PD2-04: Molecular plasticity of luminal breast cancer and response to CDK 4/6 inhibition - The biomarker program of the PENELOPE-B trial investigating post-neoadjuvant palbociclib
Bustos M., et al., Cell-free plasma microRNAs that identify patients with glioblastoma
Haslbauer, J., et al., Immunohistochemical and Transcriptional Analysis of SARS-CoV-2 Entry Factors and Renin-Angiotensin-Aldosterone System Components in Lethal COVID-19
Download pdf 1.3MB
View External Link
Haslbauer, J., et al., Vascular Damage, Thromboinflammation, Plasmablast Activation, T-Cell Dysregulation and Pathological Histiocytic Response in Pulmonary Draining Lymph Nodes of COVID-19
Download pdf 11.1MB
View External Link
Clark, C. et al., Blood-based multi-omic signatures of blood-brain barrier impairment and CSF-defined Alzheimer disease in older adults
Page last updated June 23, 2022